SpectraCell Laboratories, Inc., is a specialized clinical testing laboratory company. It was established in 1993 to commercialize a patented, groundbreaking technology for micronutrient testing.
The technology was developed at the University of Texas, by the Clayton Foundation for Research, as a diagnostic blood test for helping clinicians assess the intracellular function of essential micronutrients.
Nutritional Status & Health
Implications in Common Chronic Conditions
Overwhelming scientific evidence confirms that vitamin deficiencies are associated with disease processes and the overall condition of one’s health. Vitamin, mineral and antioxidant deficiencies have been shown to suppress immune function and contribute to chronic degenerative processes such as arthritis, cancer, Alzheimer’s, cardiovascular disease and diabetes. This body of research has been reaffirmed by the Journal of the American Medical Association (June 19, 2002-Vol 287, No 23).
MicroNutrient Testing from SpectraCell Laboratories
SpectraCell Laboratories, Inc. is a CLIA accredited clinical laboratory that specializes in a MicroNutrient Test. This patented process resulted from 18 years of research at the University of Texas. The MicroNutrient Test measures how micronutrients are actually functioning within white blood cells. These tests allow nutritional assessment of the patients for a broad variety of clinical conditions including arthritis, cancer, cardiovascular risk, diabetes, various immunological disorders, metabolic disorders and micronutrient deficiencies.
SpectraCell’s Tests are more advanced than other laboratory tests
Before the introduction of these tests, many diagnosis and risk assessments were based on clinical observation and measurements of static levels of certain nutrients in serum. Static serum levels are not always representative indicators for assessing cell metabolism and utilization.
SpectraCell’s MicroNutrient Test offers a unique means to scientifically assess the intracellular requirements of micronutrients that play an important role in overall health and wellness of the patients. These tests measure the biochemical function of vitamins, minerals, amino acids and antioxidants, providing a powerful clinical assessment tool for our practice.
“Although the clinical syndromes of vitamin deficiencies are unusual in Western societies, suboptimal vitamin status is not. Because suboptimal vitamin status is associated with many chronic diseases, including cardiovascular diseases, cancer and osteoporosis, it is important for physicians to identify patients with poor nutrition or other reasons for increased vitamin needs”
-The Journal of the American Medical Association, June 19, 2002-Vol 287, No 23, pg 3124
SpectraCell’s Patented Technology
SpectraCell’s patented, chemically-defined control media contains the minimal amount of each essential micronutrient that is needed to support optimal lymphocyte growth or mitogenic response. The functional intracellular status of micronutrients involved in cell metabolism is evaluated by manipulation of the individual micronutrients in the media followed by mitogenic stimulation and measurement of DNA synthesis.
The same technology also provides a total antioxidant function test (SPECTROX™) which assesses the ability of cells to resist damage caused by free radicals and other forms of oxidative stress. Due to the considerable number of cellular antioxidants with extensive interactions, redundancies, repair and recharging capabilities, measuring total function is the most accurate and clinically useful way to assess our patients’ capacity to resist oxidative damage.
Since lymphocytes are produced in the bone marrow and stored in the peripheral locations for long periods of time (the average life span of a lymphocyte is approximately four to six months), SpectraCell’s measurements provide a powerful portrait of each patients’ long-term nutrient status. This is analogous to the use of a glycosylated hemoglobin test to evaluate blood glucose levels over a one to three month period.
The MicroNutrient diagnostic profiles offer a window to the cell that can provide improved healthcare for all patients. However, the potential for clinical benefit is particularly evident in these patient groups:
DISEASE THERAPY AND MANAGEMENT: Diagnose and treat nutritional risk factors that contribute to the therapy/management of many degenerative disease conditions.
FAMILY HISTORY: Provide prevention measures for patients with family history of common chronic disease conditions.
HIGH RISK GROUPS: Certain high risk groups are more susceptible to vitamin, mineral and antioxidant deficiencies that can affect treatment outcomes and overall health.
PROACTIVE RISK ASSESSMENT: Provide customized prevention by early detection of nutritional deficiencies for proactive patients.
CHALLENGING CASES: Gain insight into generalized complaints with no apparent specific disease source and to provide treatment options based on biochemical individuality.
There is overwhelming evidence that vitamin deficiencies are associated with the chronic disease process and the overall condition of one’s health.
“Inadequate intake or subtle deficiencies in several vitamins are risk factors for chronic diseases such as cardiovascular disease, cancer and osteoporosis.”
-The Journal of the American Medical Association, June 19, 2002 Vol 287. No 23